Contributors
-
TwentyTwentyTweets
-
Join 7,195 other subscribers
-
Recent Posts
Pages
Category Archives: David Cameron
Threats to Mankind from Drug Resistant Bacteria and Viruses
The risk of an end to the human race may sound like science fiction. However, there are only a small number of threats that could theoretically lead to the extinction of mankind. The four main concerns that most experts share … Continue reading
Posted in Business, David Cameron, Drugs, Global Health, GPs, International, Most Significant, NHS, Pharma, Public Health, Rare conditions, Research, Vaccination
Tagged 2020health, AIDS, amoxicillin, Antibacterial, antibiotics, antiviral, Augmentin, bacteria, bacterial susceptibility, beta-lactam, beta-lactamase, bureaucracy, carpenem, cephalosporin, Ebola, end of mankind, Gilead, hepatitis, Hospitals, Human, hygiene, isolation, monobactam, NICE, pathogen, penicillin, plague, PPRS, prescribing, prevention, Prime Minister, Pseudomonas, R & D, R&D, rabies, Research, Research and development, resistance, sofosbuvir, Sovaldi, vaccine, virus, WHO
Comments Off on Threats to Mankind from Drug Resistant Bacteria and Viruses
Guest Blogspot: Waiting for Decisions on UK Pharmaceutical Pricing
Little has been heard over how confidential talks between the Government and the pharmaceutical industry are progressing towards the goal of having a new, voluntary UK drug pricing system in place in 2014. In the eyes of the pharmaceutical companies … Continue reading
Posted in Andrew Lansley, Business, Children, Commissioning, David Cameron, Department of Health, Drugs, Emerging technologies, equality, Health and Wellbeing, Innovation, Jeremy Hunt, Uncategorized, Wellbeing
Tagged 2020health, Andrew Lansley, Bowel Cancer UK, Cancer Research UK, Drugs, government, innovation, medicine, Multiple Sclerosis Society, pharmaceutical, R&D, value-based, value-based pricing
1 Comment
Pressure is rising on Sir David Nicholson
At last – some will say – MPs have begun to put their heads above the parapet and call for the resignation of the Chief Executive of the NHS in an Early day Motion today. David Nicholson was the man … Continue reading
Guest Blogspot: Think carefully about value-based drug pricing in the UK and let common sense prevail.
David Cameron and Jeremy Hunt share an important skill. They both have firsts from Oxford in Politics, Philosophy and Economics (PPE). I am not the greatest fan of this course because I would like to see more scientists, engineers and … Continue reading
Posted in Business, competition, David Cameron, Department of Health, Drugs, Election, Jeremy Hunt, NHS, Patients, Pharma, Policy, Primary Care
Tagged 2020health, block-buster, competition, David Cameron, demand, Department of Health, drug pricing system, Drugs, elderly, GP, GPs, Health Bill, innovation, medicine, National Health Service, NHS, NICE, parallel exports, parallel imports, patient, Patients, pharmaceutical, Philosophy and Economics, Politics, PPE, PPRS, pricing, quality of life, R&D, reference price, Research, value-based, value-based pricing, VBP
Leave a comment
The Health and Social Care Bill: Final Stages in Parliament
With opposition to the Health and Social Care Bill having reached new heights, we must look behind the rhetoric and remember basic principles. The most important point to remember is that the NHS exists to provide the best possible, affordable … Continue reading
Posted in Andrew Lansley, Business, Commissioning, competition, David Cameron, Department of Health, GPs, Health Bill, Hospitals, Inequality, NHS, Patient choice, Patients
Tagged 2020health, Andrew Lansley, Bevan, BMA, bureaucracy, Commissioning, competition, David Cameron, Department of Health, efficiency, government, GP, GPs, health, Health Bill, inaccurate media, National Health Service, NHS, NICE, Nye Bevan, Old age, patient, Patients, Responsibility in healthcare
Leave a comment
Guest Blogspot: Misleading, Biased Reporting on the Health and Social Care Bill in the Media
Above all the freedom of the Press is paramount. Censorship or severely restrictive legislation is not an acceptable alternative. We sometimes have to accept the consequences and tolerate a Press that can be wrong, unfair, misleading or more interested in … Continue reading
Posted in Andrew Lansley, competition, David Cameron, Department of Health, equality, Finance, Health Bill, Hospitals, Inequality, NHS, Patients, Private
Tagged 2020health, Andrew Burnham, Andrew lansley, Andy Burnham, BBC, Biased reporting, competition, David Cameron, Department of Health, Freedom of the Press, government, Health Bill, hospital beds, journalists, Labour Party, Misleading reporting, National Health Service, NHS, non-NHS income, non-NHS work, patient, Patients, Press, private income cap, private patients, Shirley Williams, theatre time, waiting times
6 Comments
PM announces Nursing Quality Forum
The Prime Minister announced today the creation of a Nursing Quality Forum to review standards of care in hospitals. The announcement came following a CQC finding that one in five hospitals fails to meet basic standards of care for elderly … Continue reading
Posted in David Cameron, Elderly, Hospitals, NHS, Nursing
Tagged David Cameron, elderly, NHS, nursing, patient, Responsibility in healthcare
Leave a comment
Political Mood Change over the NHS, Innovation and the Pharmaceutical Industry in 2011
As 2011 draws to a close now is a good time to reflect on the period since the last UK General Election in 2010. We must consider what we have done right, what we have done wrong and what remains … Continue reading
Posted in Business, David Cameron, Department of Health, Drugs, Election, Genetics, Health Bill, Health Team, Hospitals, Innovation, NHS, Pharma, Policy, Research
Tagged 2020health, David Cameron, Department of Health, Drugs, genetics, government, GPs, Health Bill, innovation, medicine, National Health Service, NHS, NICE, Pfizer, pharmaceutical, PPRS, pricing, R&D, Research, value-based, value-based pricing
Leave a comment
Open Government – Pouring Sunlight over the Department of Health
Guest Blog – Stuart Carroll “If people don’t know what you’re doing, they don’t know what you’re doing wrong”. This was the legendary advice of the circuitous Sir Humphrey Appleby to the hapless Jim Hacker in the first ever episode … Continue reading
Posted in David Cameron, Department of Health
Tagged consultation, Department of Health, pharmacueticals, pricing, Transparency
Leave a comment
Guest Blogspot: NHS Reforms- What the UK Government Policy Changes Really Mean
There is a strong consensus amongst independent experts, medical professionals and politicians that major NHS reforms are both desirable and inevitable. Healthcare is one of mankind’s greatest priorities. An aging population and medical advances mean that healthcare expenditure is bound … Continue reading
Posted in Andrew Lansley, Business, competition, David Cameron, Department of Health, Drugs, Elderly, GPs, Health Bill, Hospitals, NHS, Policy, Research, White Paper
Tagged 2020health, Andrew lansley, cherry picking, Commissioning, competition, David Cameron, Department of Health, elderly, GP, GPs, health, Health and Social Care Bill, Health Bill, Ipsos MORI, National Health Service, NHS, NHS Reforms, Patients, pricing, Quality, R&D, Research
Leave a comment
2020health's Blog 
You must be logged in to post a comment.